Pulmonary histoplasmosis

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 2, 2008, Pages 151-165

  Hage, Chadi A ^a,b   Wheat, L Joseph ^c   Loyd, James ^d   Allen, Stephen D ^a   Blue, Deborah ^a   Knox, Kenneth S ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MIRAVISTA DIAGNOSTICS   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen; Diagnosis; Histoplasmosis; Serology; Treatment

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CORTICOSTEROID; ITRACONAZOLE; METHYLPREDNISOLONE; PREDNISONE;

ACUTE LUNG HISTOPLASMOSIS; ADD ON THERAPY; ANTIGEN DETECTION; CHRONIC DISEASE; DRUG DOSE REDUCTION; FIBROSING MEDIASTINITIS; GRANULOMA; HISTOPATHOLOGY; HISTOPLASMOSIS; HUMAN; LUNG HISTOPLASMOSIS; LUNG LAVAGE; LYMPHADENITIS; MEDIASTINAL LYMPHADENITIS; MEDIASTINITIS; POLYMERASE CHAIN REACTION; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSIVE DISSEMINATED HISTOPLASMOSIS; RECOMMENDED DRUG DOSE; REVIEW; SEROLOGY; STENT;

ANTIFUNGAL AGENTS; HISTOPLASMOSIS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG DISEASES, FUNGAL; SEROLOGIC TESTS;

EID: 41149180915     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1063854     Document Type: Review

References (83)

1. Wheat LJ, Conces DJ, Allen S, Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med 2004;25:129-144
2. Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 2007;20:115-132
3. Wheat LJ. Improvements in diagnosis of histoplasmosis. Expert Opin Biol Ther 2006;6:1207-1221
4. Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med 1986;314:83-88
5. Durkin MM, Connolly PA, Wheat LJ. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J Clin Microbiol 1997;35:2252-2255
6. Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997;24:1169-1171
7. Wheat LJ, Connolly P, Durkin M, et al. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies. Transpl Infect Dis 2004;6:23-27
8. Wheat LJ, Connolly P, Durkin M, Book BK, Pescovitz MD. Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay. Transpl Infect Dis 2006;8:219-221
9. Wheat LJ, Witt J III, Durkin M, Connolly P. Reduction in false antigenemia in the second generation Histoplasma antigen assay. Med Mycol 2007;45:169-171
10. Kuberski T, Myers R, Wheat LJ, Kubak BM, Bruckner D, Peuges D. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin Infect Dis 2007;44:e50-e54
11. Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007;14:1587-1591
12. Williams B, Fojtasek M, Connolly-Stringfield P, Wheat J. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch Pathol Lab Med 1994;118:1205-1208
13. Davies SF. Serodiagnosis of histoplasmosis. Semin Respir Infect 1986;1:9-15
14. Wheat LJ. Current diagnosis of histoplasmosis. Trends Microbiol 2003;11:488-494
15. Wheat LJ, Garringer T, Brizendine E, Connolly P. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn Microbiol Infect Dis 2002;43:29-37
16. Wheat J, French ML, Kohler RB, et al. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med 1982;97:680-685
17. Sacks JJ, Ajello L, Crockett LK. An outbreak and review of cave-associated histoplasmosis capsulati. J Med Vet Mycol 1986;24:313-327
18. Hage CA, Davis TE, Egan L, et al. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay. Respir Med 2007;101:43-47
19. Wheat LJ, Connolly-Stringfield P, Blair R, Connolly K, Garringer T, Katz BP. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med 1991;115:936-941
20. Wheat LJ, French MLV. The diagnostic approach in histoplasmosis. Immunol Allergy Pract V 1983;9:19-28
21. Larrabee WF, Ajello L, Kaufman L. An epidemic of histoplasmosis on the isthmus of Panama. Am J Trop Med Hyg 1978;27:281-285
22. Zimmerman SE, French MLV, Kleiman MB, Wheat LJ. Evaluation of an enzyme-linked immunosorbent assay that uses ferrous metal beads for determination of antihistoplasmal immunoglobulins G and M. J Clin Microbiol 1990;28:59-64
23. Guimaraes AJ, Pizzini CV, Matos Guedes HL, et al. ELISA for early diagnosis of histoplasmosis. J Med Microbiol 2004;53:509-514
24. Bialek R, Feucht A, Aepinus C, et al. Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue. J Clin Microbiol 2002;40:1644-1647
25. Tang YW, Li H, Durkin MM, et al. Urine polymerase chain reaction is not as sensitive as urine antigen for the diagnosis of disseminated histoplasmosis. Diagn Microbiol Infect Dis 2006;54:283-287
26. Ost D, Fein AM, Feinsilver SH. The solitary pulmonary nodule. N Engl J Med 2003;348:2535-2542
27. Mashburn JD, Dawson DF, Young JM. Pulmonary calcifications and histoplasmosis. Am Rev Respir Dis 1961;84:208-216
28. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007;45:807-825
29. Reynolds RJI, Penn RL, Grafton WD, George RB. Tissue morphology of Histoplasma capsulatum in acute histoplasmosis. Am Rev Respir Dis 1984;130:317-320
30. Sollod N. Acute fulminating disseminated histoplasmosis. J S C Med Assoc 1971;67:231-234
31. Sathapatayavongs B, Batteiger BE, Wheat J, Slama TG, Wass JL. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 1983;62:263-270
32. Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis: analysis of a large urban outbreak. Ann Intern Med 1982;96:159-163
33. Wynne JW, Olsen GN. Acute histoplasmosis presenting as the adult respiratory distress syndrome. Chest 1974;66:158-161
34. Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002;137:105-109
35. Goodwin RA, Loyd JE, des Prez RM. Histoplasmosis in normal hosts. Medicine (Baltimore) 1981;60:231-266
36. Scully RE, Mark EJ, McNeely WF, McNeely BU. Case records of the Massachusetts General Hospital: case 39-1991 presentation of case. N Engl J Med 1991;325:949-956
37. Greenwood MF, Holland P. Tracheal obstruction secondary to Histoplasma mediastinal granuloma. Chest 1972;62:642-645
38. Savides TJ, Gress FG, Wheat LJ, Ikenberry S, Hawes RH. Dysphagia due to mediastinal granulomas: diagnosis with endoscopic ultrasonography. Gastroenterology 1995;109:366-373
39. Jenkins DW, Fisk DE, Byrd RB. Mediastinal histoplasmosis with esophageal abscess. Gastroenterology 1976;70:109-111
40. Dines DE, Payne WS, Bernatz PE, Pairolero PC. Mediastinal granuloma and fibrosing mediastinitis. Chest 1979;75:320-324
41. Davis AM, Pierson RN, Loyd JE. Mediastinal fibrosis. Semin Respir Infect 2001;16:119-130
42. Goodwin RA, Nickell JA, des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 1972;51:227-246
43. Weinstein JB, Aronberg DJ, Sagel SS. CT of fibrosing mediastinitis: findings and their utility. AJR Am J Roentgenol 1983;141:247-251
44. Loyd JE, Tillman BF, Atkinson JB, des Prez RM. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 1988;67:295-310
45. Doyle TP, Loyd JE, Robbins IM. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am J Respir Crit Care Med 2001;164:657-660
46. Recto MR, Bousamra M, Yeh T. Late superior vena cava perforation and aortic laceration after stenting to treat superior vena cava syndrome secondary to fibrosing mediastinitis. J Invasive Cardiol 2002;14:624-629
47. Mathisen DJ, Grillo HC. Clinical manifestations of mediastinal fibrosis and histoplasmosis. Ann Thorac Surg 1992;54:1053-1058
48. Wheat LJ, Slama TG, Eitzen HE, Kohler RB, French ML, Biesecker JL. A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med 1981;94:331-337
49. Wheat LJ, Wass J, Norton J, Kohler RB, French ML. Cavitary histoplasmosis occurring during two large urban outbreaks: analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 1984;63:201-209
50. Goodwin RA Jr, Owens FT, Snell JD, et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976;55:413-452
51. Furcolow ML. Comparison of treated and untreated severe histoplasmosis. JAMA 1963;183:121-127
52. Putnam LR, Sutliff WD, Larkin JC, et al. Histoplasmosis cooperative study: chronic pulmonary histoplasmosis treated with amphotericin B alone and with amphotericin B and triple sulfonamide. Am Rev Respir Dis 1968;97:96-102
53. Adderson EE. Histoplasmosis in a pediatric oncology center. J Pediatr 2004;144:100-106
54. Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients: two large urban outbreaks. Arch Intern Med 1983;143:703-707
55. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large midwestern university transplant center. Transpl Infect Dis 2005;7:109-115
56. Wheat J. Histoplasmosis in the acquired immunodeficiency syndrome. Curr Top Med Mycol 1996;7:7-18
57. Tucker RM, Denning DW, Hanson LH, et al. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. Clin Infect Dis 1992;14:165-174
58. Odio CM, Navarrete M, Carrillo JM, Mora L, Carranza A. Disseminated histoplasmosis in infants. Pediatr Infect Dis J 1999;18:1065-1068
59. Leggiadro RJ, Barrett FF, Hughes WT. Disseminated histoplasmosis of infancy. Pediatr Infect Dis J 1988;7:799-805
60. Goodwin RA Jr, Shapiro JL, Thurman GH, Thurman SS, des Prez RM. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 1980;59:1-33
61. Wood KL, Hage CA, Knox KS, et al. Histoplasmosis after treatment with anti-TNF-α therapy. Am J Respir Crit Care Med 2003;167:1279-1282
62. Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002;46:2565-2570
63. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004;38:1261-1265
64. Kortsik C, Elmer A, Tamm I. Pleural effusion due to Histoplasma capsulatum and idiopathic CD4 lymphocytopenia. Respiration 2003;70:118-122
65. Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005;41:e38-e41
66. Conces DJ Jr, Stockberger SM, Tarver RD, Wheat LJ. Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol 1993;160:15-19
67. Corcoran GR, Al-Abdely H, Flanders CD, Geimer J, Patterson TF. Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1997;24:942-944
68. Kirn DH, Fredericks D, McCutchan JA, Stites D, Shuman M. Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis. Clin Infect Dis 1995;21:1048-1049
69. Sarosi GA, Voth DW, Dahl BA, Doto IL, Tosh FE. Disseminated histoplasmosis: results of long-term follow-up: a Center for Disease Control Cooperative Mycoses Study. Ann Intern Med 1971;75:511-516
70. Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002;137:105-109
71. Dismukes WE, Bradsher RW, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med 1992;93:489-497
72. Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med 1995;98:336-342
73. Wheat J, Hafner R, Wulfsohn M, et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. The National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators. Ann Intern Med 1993;118:610-616
74. Hecht FM, Wheat J, Korzun AH, et al. Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:100-107
75. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis 2004;38:1485-1489
76. Wheat LJ, Connolly P, Smedema M, et al. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother 2006;57:1235-1239
77. Connolly P, Wheat LJ, Schnizlein-Bick C, et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother 2000;44:2604-2608
78. Connolly P, Wheat J, Schnizlein-Bick C, et al. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice. Antimicrob Agents Chemother 1999;43:322-328
79. Restrepo A, Tobon A, Clark B, et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007;54:319-327
80. Wheat J, MaWhinney S, Hafner R, et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Am J Med 1997;103:223-232
81. Wheat LJ, Connolly P, Smedema M, Brizendine E, Hafner R. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. Clin Infect Dis 2001;33:1910-1913
82. Walsh TJ, Raad I, Patterson TF, et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 2007;44:2-12
83. Freifeld A, Arnold S, Ooi W, et al. Relationship of blood level and susceptibility in voriconazole treatment of histoplasmosis. Antimicrob Agents Chemother 2007;51:2656-2657